Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 InfectionSorana Segal‐Maurer, Jean‐Michel Molina, Antonella Castagna et al.|New England Journal of Medicine|2022Cited by 312
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trialOnyema Ogbuagu, Hui Wang, Nicolas Margot et al.|The Lancet HIV|2023Cited by 71